ML
TTOO

McAdam LLC’s T2 Biosystems, Inc TTOO Stock Holding History

McAdam LLC’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,132
Closed -$58K – 280
2022
Q4 		$58K Buy
1,132
+1,109
+4,822% +$228K 0.01% 191
2022
Q3 		$13K Hold
23
– – ﹤0.01% 215
2022
Q2 		$18K Hold
23
– – ﹤0.01% 218
2022
Q1 		$59K Hold
23
– – 0.01% 207
2021
Q4 		$58K Buy
23
+8
+53% +$27.8K 0.01% 191
2021
Q3 		$69K Buy
15
+1
+7% +$5.03K 0.01% 177
2021
Q2 		$72K Sell
14
-2
-13% -$12.9K 0.01% 174
2021
Q1 		$126K Hold
16
– – 0.02% 156
2020
Q4 		$128K Hold
16
– – 0.02% 157
2020
Q3 		$106K Buy
16
+11
+220% +$81.5K 0.02% 138
2020
Q2 		$32K Buy
+5
New +$21.2K 0.01% 123

Other funds holding TTOO

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

McAdam LLC's TTOO Position: Q1 2023 in Review

McAdam LLC sold out of T2 Biosystems, Inc (TTOO) in Q1 2023, closing a stake of 1,132 shares — an estimated $58K sold.

McAdam LLC first reported a position in TTOO in Q2 2020 and held it in 11 quarters. The position peaked at $128K in Q4 2020. 28 funds tracked by Wall St. Rank hold TTOO as of Q1 2023.

  • McAdam LLC reported no remaining T2 Biosystems, Inc position as of Q1 2023 after selling out during the quarter.
  • McAdam LLC sold 1,132 T2 Biosystems, Inc shares in Q1 2023, an estimated $58K.
  • McAdam LLC first reported a position in T2 Biosystems, Inc in Q2 2020 and held it in 11 quarters.
  • McAdam LLC's T2 Biosystems, Inc position peaked at $128K in Q4 2020.
  • 28 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q1 2023.

Based on McAdam LLC's 13F filing for Q1 2023, filed 24 Apr 2023.